> I’m fond of saying that the most important single statistic about the drug industry is the clinical failure rate, which is (by any reasonable standard) appallingly high. He starts off on the wrong note, there is nothing at all wrong with a high rate of clinical failures. If anything, the reasonable argument standard might be that this rate is too low. It implies researchers are trying things that they expect to hav…
Clinical failure rates over the decades: yikes
21–30 of 146 posts
Re: Clinical failure rates over the decades: yikes
#22Roughly equivalent to the percentage of startups that fail. Lower numbers don’t mean we’re doing better, it means we’re trying less.
ugh, I don't know
Re: Clinical failure rates over the decades: yikes
#23> I’m fond of saying that the most important single statistic about the drug industry is the clinical failure rate, which is (by any reasonable standard) appallingly high. He starts off on the wrong note, there is nothing at all wrong with a high rate of clinical failures. If anything, the reasonable argument standard might be that this rate is too low. It implies researchers are trying things that they expect to hav…
If this try or die mentality does work, why don't we try every possible amino acid chain in every configuration possible? It's an infinitesimally small chance but try or die "outweighs". This is evidently absurd.
Re: Clinical failure rates over the decades: yikes
#24Re: Clinical failure rates over the decades: yikes
#25I’ve been hearing for 10 years now on how “AI” will change this clinical rate. It’s now like the “This is the year of Linux” prediction meme. And like Derek has mentioned multiple times you can’t statiscialise biology. I don’t think many people get it so we have tech bros like us throw AI at data.
Re: Clinical failure rates over the decades: yikes
#26I'm actually surprised it isn't going up over time. That is naively what you would expect as the low-hanging fruit is plucked. So the fact that it's been stable is probably a sign that scientific advances are roughly keeping pace with the (presumably) increasing challenge of finding ever more targets for drugs.
Yes, the science advances, previously high-hanging fruits become low-hanging become high-hanging again [1], but the tooling also advances: we now have databases like OpenTargets which let us more easily evaluate potential drug targets. Failure is so much more than that, though: a program can fail after you've shown efficacy in animals, sometimes it just doesn't happen in the human subjects. Or you fail to find the right measurement (endpoint). A million ways to die.
[1] Gene editing is an example: impossible, then very possible, but now the blocker is public perception which in turn blocks investment.
Re: Clinical failure rates over the decades: yikes
#27Roughly equivalent to the percentage of startups that fail. Lower numbers don’t mean we’re doing better, it means we’re trying less.
Their goal often seems not to be toward a successful, sustainable product. They just market their vision in the hopes of being acquired.
A few fewer failures might not be entirely a bad thing.
Re: Clinical failure rates over the decades: yikes
#28> I’m fond of saying that the most important single statistic about the drug industry is the clinical failure rate, which is (by any reasonable standard) appallingly high. He starts off on the wrong note, there is nothing at all wrong with a high rate of clinical failures. If anything, the reasonable argument standard might be that this rate is too low. It implies researchers are trying things that they expect to hav…
Rather notably, companies are profit-driven, not good-for-society driven. If 99% of your attempts which cost millions to do fail, the company either has to raise the prices of the drug insanely high or not work as a company. In addition, most drugs aren't humanity saving or crucial for humans to live. You could solve all forms of cancer tomorrow, which would be a great thing, but you aren't "saving humanity". You add…
> If this try or die mentality does work, why don't we try every possible amino acid chain in every configuration possible?
You tell me. If someone wants to start working through the amino acids one by one I'm not going to say they should be stopped; sincerest good luck to them. I'm just not going to be the one funding it.
> You could solve all forms of cancer tomorrow, which would be a great thing, but you aren't "saving humanity".
This is a straw man. "Saving humanity", whatever that means, is outside the scope of medicine and I never argued for it. Nobody did. It isn't relevant.
Re: Clinical failure rates over the decades: yikes
#29This is completely unsurprising, and this: But let’s think about that 91% failure rate for a moment. When I bring this up in presentations, I invite the audience to consider what the auto industry would look like of 91% of new car designs proved unable to roll out of the factory, or if 91% of new airliner models were unable to leave the ground Is an utterly irrelevant comparison. For physical thing we have engineerin…
I don't think its irrelevant, but a better comparison would be to what vacuum tube development looked like before we understood electrons. There were some very whacky designs and most of them didn't work for crap.
And, yeah, I would argue that PCR shifted us from the alchemy phase of biology to the science phase and now mRNA has shifted us from the science phase of biology to t he engineering phase of biology. We're just getting started.
Re: Clinical failure rates over the decades: yikes
#30Roughly equivalent to the percentage of startups that fail. Lower numbers don’t mean we’re doing better, it means we’re trying less.
I’m not entirely sure other startups necessarily want to succeed… Their goal often seems not to be toward a successful, sustainable product. They just market their vision in the hopes of being acquired. A few fewer failures might not be entirely a bad thing.
The missing ingredient of course is the people. We cannot let this country pretend it's functional when it invests so poorly. Any sane version of the us will expect years if nit decades of economic pain before these investments pay off